Summary of Key Points Core Viewpoint - Tianyuan Medical (00557.HK) anticipates a significant decline in total revenue for the six months ending June 30, 2025, projecting approximately HKD 8.4 million, a decrease of about 44% compared to approximately HKD 14.9 million for the previous period [1][3]. Revenue Decline Reasons - The primary reason for the expected revenue decrease is the suspension of operations and renovations at Shanghai Yuyue Weilai Medical Beauty Hospital, which is partially owned by the group. This is expected to result in a revenue drop of no less than approximately HKD 6.2 million, reducing medical business revenue to about HKD 0.5 million (previous period: approximately HKD 6.7 million) [3]. Net Loss Projection - The company projects a net loss of approximately HKD 8.4 million for the interim period, compared to a net loss of approximately HKD 9 million for the previous period. This anticipated loss is primarily attributed to the estimated decrease in total revenue, offset by a corresponding reduction in operating costs [3]. Business Overview - Tianyuan Medical's main business activities include investment holding, providing procurement, marketing, management, franchising, and plastic surgery services to the medical industry, as well as lending and related services, and offering procurement services to the hotel industry [3].

Group 1 - The competition theme is "Technology Leads Aesthetic Surgery, Innovation Drives The Future" [4] - The event is organized by Beijing Ba Da Chu Plastic Surgery Medical Technology Group Co., Ltd. and Zhongguancun Medical Device Park Co., Ltd. [4] - The competition aims to promote innovative projects in the field of aesthetic surgery and medical beauty [4][5] Group 2 - The competition structure includes various regional competitions, each led by an academic leader who coordinates resources and manages the event [7] - The competition is divided into several regional areas, including East, South, West, North, and Central regions, covering multiple provinces [8] Group 3 - Participants must be from medical institutions, universities, or innovative enterprises in the aesthetic field, with a focus on projects related to plastic surgery, medical beauty, and related technologies [22] - The evaluation committee consists of clinical experts and transformation experts, with a total of 10-15 judges [22] Group 4 - The evaluation criteria include innovation, technical feasibility, market potential, team capability, and transformation potential, with specific weightings assigned to each dimension [23] - Awards include first, second, and third prizes, along with excellence awards, with monetary rewards and service packages for winners [25] Group 5 - The competition timeline includes a registration phase from June 10 to August 31, 2025, followed by preliminary evaluations and finals in September and October [25][26] - The final event will feature a forum and project roadshow, culminating in the announcement of winners [26]